Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers
January 25, 2018, Mayo Clinic
Credit: CC0 Public Domain
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.